Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-24 @ 10:34 PM
NCT ID:
NCT03732235
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent
* \>18 years old;
* diagnosed with unresectable CRC-LM (for reasons of anatomy, co-morbidity, patient's wishes, lack of response to standard therapy with intravenous or oral fluoropyrimidine, oxaliplatin, irinotecan or biological agents (bevacizumab, cetuximab, panitumumab);
* Eastern Cooperative Oncology Group (ECOG) 0-1;
* measurable tumor size by mRECIST \[6\];
* ≤40% liver involvement;
* a life expectancy of at least 3 months,
* blood biochemistry within the normal range.
Exclusion Criteria:
* contraindication for angiographic catheterization;
* extensive extra-hepatic disease;
* pregnancy or breast-feeding,
* other severe clinical contraindications (e.g. liver failure, ascites, cardiovascular diseases and/or chronic obstructive pulmonary disease).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03732235
Study Brief:
Protocol Section:
NCT03732235